Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Eli Lilly’s partner Junshi doses first patient in Covid-19 trial with JS016 investigational medicine
Eli Lilly’s partner Junshi has dosed first patient in Covid-19 trial with JS016 investigational medicine. (Credit: Visuals3D from Pixabay)
Eli Lilly’s partner Junshi has dosed first patient in Covid-19 trial with JS016 investigational medicine. (Credit: Visuals3D from Pixabay)